Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
161. |
ECCT/22/01/06 | AIKILI Technology Feasibility and accuracy of nanosensor-based breast cancer diagnosis at the point-of-care-AIKILI technology |
Principal Investigator(s) 1. Laura Kelley Kelley Site(s) in Kenya Aga Khan University Hospital, Nairobi. |
View |
162. |
ECCT/21/10/05 | Lactolize Study Lactoferrin and Lysozyme supplementation for long-term diarrhea sequelae |
Principal Investigator(s) 1. Benson Ochieng Singa Site(s) in Kenya 1. Awendo Sub-County Hospital (Migori county) 2. Homa Bay County Referral Hospital (Homa Bay county) 3. Isebania Sub-County Hospital (Migori county) 4. Kendu Adventist Hospital (Homa Bay county) 5. Kisii Teaching and Referral Hospital (Kisii county) 6. Mbita Sub-County Hospital (Homa Bay county) 7. Rongo Sub-County Hospital (Migori county) |
View |
163. |
ECCT/14/08/03 | STAND Study (Shortening Treatment by Advancing Novel Drugs) Long Title: A Phase 3 Open Label Partially Randomised Trial to Evaluate the Efficacy, Safety and Tolerability of the Combination of Moxifloxacin plus PA-824 plus Pyrazinamide after 4 and 6 months of Treatment in Adult Subjects with Drug Sensitive Smear Positive Pulmonary Tuberculosis and after 6 months of Treatment in Adult Subjects with Multi-Drug Resistant, Smear-Positive Pulmonary Tuberculosis Short Title: STAND Study (Shortening Treatment by Advancing Novel Drugs) |
Principal Investigator(s) 1. Dr Videlis Nduba 2. Dr Evans Amukoye Site(s) in Kenya 1. KEMRI-CRDR(East Nairobi) (Nairobi City county) 2. KEMRI-CRDR(West Nairobi) (Nairobi City county) |
View |
164. |
ECCT/23/05/07 | LATA Long-Acting Treatment in Adolescents (LATA) A randomised open-label 2-arm 96 week trial in virologically suppressed HIV-1-positive adolescents aged 12-19 years of age in Sub-Saharan Africa |
Principal Investigator(s) 1. Abraham Siika Site(s) in Kenya 1. |
View |
165. |
ECCT/24/03/05 | 221163 PALISADE Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition |
Principal Investigator(s) 1. Grace Mboya Site(s) in Kenya KEMRI Kisumu Clinical Research Site |
View |